Shah, S. J., Borlaug, B. A., Chung, E. S., Cutlip, D. E., Debonnaire, P., Fail, P. S., Gao, Q., Hasenfuß, G., Kahwash, R., Kaye, D. M., Litwin, S. E., Lurz, P., Massaro, J. M., Mohan, R. C., Ricciardi, M. J., Solomon, S. D., Sverdlov, A. L., Swarup, V., van Veldhuisen, D. J., Winkler, S., Leon, M. B., , , Akar, J., Ando, J., Anzai, T., Asakura, M., Bailey, S., Basuray, A., Bauer, F., Bergmann, M., Blair, J., Cavendish, J., Chung, E., Cikes, M., Dauber, I., Donal, E., Eicher, J., Fail, P., Flaherty, J., Freixa, X., Gafoor, S., Gertz, Z., Gordon, R., Guazzi, M., Guerrero-Miranda, C., Gupta, D., Gustafsson, F., Hadadi, C., Hakemi, E., Handoko, L., Hass, M., Hausleiter, J., Hayward, C., Hickey, G., Hummel, S., Hussain, I., Isnard, R., Izumi, C., Jondeau, G., Juneman, E., Kinugawa, K., Kipperman, R., Krakowiak, B., Krim, S., Larned, J., Lewis, G., Lipsic, E., Magalski, A., Mazimba, S., Mazurek, J., McGrady, M., Mckenzie, S., Mehta, S., Mignone, J., Morsli, H., Nair, A., Noel, T., Orford, J., Parikh, K., Patterson, T., Penicka, M., Petrie, M., Pieske, B., Post, M., Raake, P., Romero, A., Ryan, J., Saito, Y., Sakamoto, T., Sakata, Y., Samara, M., Satya, K., Sindone, A., Starling, R., Trochu, J., Upadhya, B., van der Heyden, J., van Empel, V., Varma, A., Vest, A., Wengenmayer, T., Westenfeld, R., Westermann, D., Yamamoto, K., & Zirlik, A. (2022). atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial. Lancet, 399(10330), 1130–1140. http://access.bl.uk/ark:/81055/vdc_100160105356.0x00004f